St. George's Vascular Institute, London, UK.
Eur J Vasc Endovasc Surg. 2010 Jun;39(6):676-82. doi: 10.1016/j.ejvs.2010.02.001. Epub 2010 Feb 24.
Recent developments in aortic stent-graft technology have led to an increase in the use of wholly percutaneous endovascular aneurysm repair (P-EVAR). The literature was systematically reviewed to analyse the results of P-EVAR.
A systematic review of P-EVAR was performed using Ovid-MEDLINE in-process and other nonindexed citations and Ovid-MEDLINE and EMBASE (January 1991-July 2009). Primary outcomes reviewed were success rate and loco-regional complications. Secondary outcomes included; operative time, hospital stay, time to ambulation, blood loss and cost. Prospective randomised and controlled nonrandomised studies were included as were case series (retrospective and prospective). Case reports, letters, review articles and non-English language articles were excluded.
Twenty-two papers were identified. These included randomised trials (n=1); prospective nonrandomised (n=10) and retrospective studies (n=11). P-EVAR was attempted in 1087 patients (1751 groins). Overall success rate of percutaneous arterial closure was 92% (90.1-93.9, 95% CI). Access related complication rate was 4.4% (3.5-5.3, 95% CI). Seven studies provided data on access related complications in open access cohorts (O-EVAR). In these studies, P-EVAR was associated with fewer access related complications (RR 0.47, 95% CI 0.28-0.78, p=0.004). P-EVAR was associated with reduced operative time.
P-EVAR appears safe and effective in selected patients. Local access related complications were low. Further work is required to identify the most suitable candidates for P-EVAR.
主动脉支架移植物技术的最新进展使得完全经皮血管内动脉瘤修复术(P-EVAR)的应用有所增加。系统回顾了文献,以分析 P-EVAR 的结果。
使用 Ovid-MEDLINE 在处理中及其他非索引引文和 Ovid-MEDLINE 和 EMBASE(1991 年 1 月至 2009 年 7 月)对 P-EVAR 进行了系统回顾。主要观察指标为成功率和局部并发症。次要结果包括手术时间、住院时间、下床时间、出血量和费用。包括前瞻性随机对照非随机研究和病例系列(回顾性和前瞻性)。病例报告、信件、综述文章和非英语语言文章被排除在外。
确定了 22 篇论文。这些论文包括随机试验(n=1);前瞻性非随机(n=10)和回顾性研究(n=11)。在 1087 例患者(1751 例腹股沟)中尝试了 P-EVAR。经皮动脉闭合的总体成功率为 92%(90.1-93.9,95%CI)。血管通路相关并发症发生率为 4.4%(3.5-5.3,95%CI)。7 项研究提供了开放通路队列(O-EVAR)中与血管通路相关的并发症数据。在这些研究中,P-EVAR 与较少的血管通路相关并发症相关(RR 0.47,95%CI 0.28-0.78,p=0.004)。P-EVAR 与手术时间缩短有关。
在选定的患者中,P-EVAR 似乎是安全有效的。局部血管通路相关并发症较低。需要进一步的工作来确定最适合 P-EVAR 的患者。